Together, these results emphasize that the severity of DFNB1 HL cannot be predicted by GJB2 genotype alone and that modifier genes and regulatory elements contribute to significant variability in phenotype [13]. The gene discussed is GJB2; the disease is Hodgkins lymphoma.